Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Daniel Freigeiro"'
Autor:
Alicia R. Bitsman, Viviana Varela, Karen G. Scheps, Sandra Pennesi, Daniel Freigeiro, Silvia M. De Paula, F. Nora Basack
Publikováno v:
Hemoglobin. 37(5)
We describe a novel frameshift mutation on the HBA1 gene (c.187delG), causative of α-thalassemia (α-thal) in a Black Cuban family with multiple sequence variants in the HBA genes and the Hb S [β6(A3)Glu→Val, GAG>GTG; HBB: c.20A>T] mutation. The
Autor:
Regina Kohan, Luis Aversa, Guillermo Drelichman, Elena Graciela, Elvira Ponce, Daniel Freigeiro, Nora Basack
Publikováno v:
The Journal of pediatrics. 151(2)
Objective To document the effects of interrupting enzyme replacement therapy (ERT) for at least 1 year in a group of children with type 1 Gaucher disease. Study design All children with type 1 Gaucher disease who were treated at 2 pediatric centers a
Autor:
Luis Aversa, Cecilia Riccheri, Mercedes Tomasetti, Monica Makiya, Sergio Gomez, Marcela Gutiérrez, Sandra Zirone, Horacio Caferri, Nestor Rossi, Carlos Hollmann, Daniel Freigeiro, Alcira Fynn, Virginia Schuttenberg, Guillermo Arbesu, David Veron, Constanza Drozdowski, Graciela Elena, Alejandra Cedola, Julieta Bietti, Bibiana Tramunt
Publikováno v:
Blood. 120:2605-2605
Abstract 2605 Introduction: The outcome in pediatric patients with relapse-refractory acute leukemia (acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML)) is very poor. Clofarabine is an active agent in this high risk group. Purpose:
Autor:
Guillermo Drelichman, Nora Basack, Daniel Freigeiro, Ernesto Rodriguez, Luis Aversa, Leonardo Feldman
Publikováno v:
Blood. 106:3752-3752
Hereditary Spherocytosis (HS) is the most common cause of non-immune hemolytic anemia in Argentine people of European ancestry, it is characterized by chronic hemolysis, which is reduced or abrogated by splenectomy.. Because of the risk of postsplene
Autor:
Graciela Schwalb, Alejandra Maro, Sandra Pennesi, Luis Aversa, Ana Awdejczuk, Daniel Freigeiro, Guillermo Drelichman, Nora Basack, Lorena Moran
Publikováno v:
Blood. 106:3751-3751
Inherited bone marrow failure syndromes (IBMFS) present chronic bone marrow failures, a familial incidence and high risk of malignancy. Objective: we describe our experience with patients with IBMFS. Since 02/73 to 02/05, 60 patients (pts) with IBMSF